Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21340%2F22%3A00357844" target="_blank" >RIV/68407700:21340/22:00357844 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1186/s41181-022-00161-4" target="_blank" >https://doi.org/10.1186/s41181-022-00161-4</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/s41181-022-00161-4" target="_blank" >10.1186/s41181-022-00161-4</a>
Alternative languages
Result language
angličtina
Original language name
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
Original language description
Background: Recent advances in nanotechnology have ofered new hope for cancer detection, prevention, and treatment. Nanomedicine, a term for the application of nanotechnology in medical and health felds, uses nanoparticles for several applica- tions such as imaging, diagnostic, targeted cancer therapy, drug and gene delivery, tissue engineering, and theranostics. Results: Here, we overview the current state-of-the-art of radiolabeled nanoparticles for molecular imaging and radionuclide therapy. Nanostructured radiopharmaceuticals of technetium-99m, copper-64, lutetium-177, and radium-223 are discussed within the scope of this review article. Conclusion: Nanoradiopharmaceuticals may lead to better development of thera- nostics inspired by ingenious delivery and imaging systems. Cancer nano-theranos- tics have the potential to lead the way to more specifc and individualized cancer treatment. Keywords: Radiolabeled nanoparticles, Technetium-99m, Copper-64, Lutetium-177, Radium-223, Molecular imaging, Radionuclide therapy, Theranostics, Toxicity, Radiopharmacy
Czech name
—
Czech description
—
Classification
Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
10402 - Inorganic and nuclear chemistry
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
EJNMMI Radiopharmacy and Chemistry
ISSN
2365-421X
e-ISSN
2365-421X
Volume of the periodical
7
Issue of the periodical within the volume
04
Country of publishing house
GB - UNITED KINGDOM
Number of pages
36
Pages from-to
1-36
UT code for WoS article
000787313000001
EID of the result in the Scopus database
2-s2.0-85128850047